The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJUKG.L Regulatory News (JUKG)

  • There is currently no data for JUKG

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Edison reviews Jupiter UK Growth Investment Trust

13 May 2019 14:56

RNS Number : 8565Y
Jupiter UK Growth Inv Trust PLC
13 May 2019
 

 

London, UK, 13 May 2019

Edison issues review on Jupiter UK Growth Investment Trust (JUKG)

Jupiter UK Growth Investment Trust (JUKG) aims to generate long-term capital growth, primarily through investing in UK-listed equities. The fund manager, Steve Davies, follows a detailed and fundamental approach to find companies with growth or recovery potential. Unconstrained by benchmark considerations, he is not afraid of being contrarian, and his approach is patient and highly selective. The portfolio consists of just 30-35 holdings and is very different from the FTSE All-Share index, therefore, short- and medium-term performance can diverge from the benchmark. The trust's NAV total return performance has lagged the benchmark over the past one and three years. This partly reflects JUKG's significant holdings in UK domestic stocks, which have been very out of favour with investors, but where the manager finds compelling long-term value.

 

JUKG currently trades at a 2.0% discount to its cum-income NAV, which is the same as its the three-year average. The shares typically trade close to its NAV, reflecting the board's nil-discount policy. The trust has a dividend yield of 2.4% and, as at end-April 2019, had net gearing of 10.3%.

Click here to view the full report.

 

All reports published by Edison are available to download free of charge from its website

www.edisongroup.com

About Edison: Edison is an investment research and advisory company, with offices in North America, Europe, the Middle East and AsiaPac. The heart of Edison is our world-renowned equity research platform and deep multi-sector expertise. At Edison Investment Research, our research is widely read by international investors, advisers and stakeholders. Edison Advisors leverages our core research platform to provide differentiated services including investor relations and strategic consulting.

Edison is authorised and regulated by the Financial Conduct Authority.

Edison is not an adviser or broker-dealer and does not provide investment advice. Edison's reports are not solicitations to buy or sell any securities.

For more information please contact Edison:

Helena Coles, +44 (0)20 3681 2522

Mel Jenner, +44 (0)20 3077 5720

investmenttrusts@edisongroup.com

 

Learn more at www.edisongroup.com and connect with Edison on:

LinkedIn https://www.linkedin.com/company/edison-investment-research 

Twitter www.twitter.com/Edison_Inv_Res 

YouTube www.youtube.com/edisonitv 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
NRAAJMJTMBABBJL
Date   Source Headline
24th Mar 202110:08 amRNSNet Asset Value(s)
23rd Mar 202110:48 amRNSNet Asset Value(s)
22nd Mar 202110:15 amRNSNet Asset Value(s)
19th Mar 202110:44 amRNSNet Asset Value(s)
18th Mar 20215:30 pmRNSJupiter UK Growth Investment Trust
18th Mar 202111:50 amRNSPortfolio Update
18th Mar 202110:16 amRNSNet Asset Value(s)
17th Mar 202110:23 amRNSNet Asset Value(s)
16th Mar 20219:34 amRNSNet Asset Value(s)
15th Mar 20212:00 pmRNSResult of First GM, Elections and update on DRIP
15th Mar 202110:37 amRNSNet Asset Value(s)
12th Mar 20219:40 amRNSNet Asset Value(s)
11th Mar 20219:55 amRNSNet Asset Value(s)
10th Mar 20219:58 amRNSNet Asset Value(s)
9th Mar 202110:26 amRNSNet Asset Value(s)
8th Mar 20219:45 amRNSNet Asset Value(s)
5th Mar 202110:11 amRNSNet Asset Value(s)
4th Mar 202110:43 amRNSNet Asset Value(s)
3rd Mar 202110:04 amRNSNet Asset Value(s)
2nd Mar 20219:47 amRNSNet Asset Value(s)
1st Mar 202110:36 amRNSNet Asset Value(s)
26th Feb 20216:08 pmRNSTotal Voting Rights
26th Feb 202111:16 amRNSNet Asset Value(s)
25th Feb 202110:16 amRNSNet Asset Value(s)
24th Feb 202110:18 amRNSNet Asset Value(s)
23rd Feb 202110:33 amRNSNet Asset Value(s)
22nd Feb 202110:55 amRNSNet Asset Value(s)
19th Feb 20219:43 amRNSNet Asset Value(s)
19th Feb 20217:00 amRNSPublication of Circular
19th Feb 20217:00 amRNSDividend Declaration
18th Feb 20219:45 amRNSNet Asset Value(s)
17th Feb 202111:03 amRNSNet Asset Value(s)
16th Feb 202110:21 amRNSNet Asset Value(s)
15th Feb 20215:20 pmRNSPortfolio Update
15th Feb 202110:13 amRNSNet Asset Value(s)
12th Feb 202111:39 amRNSNet Asset Value(s)
11th Feb 202110:13 amRNSNet Asset Value(s)
10th Feb 202110:04 amRNSNet Asset Value(s)
9th Feb 20219:49 amRNSNet Asset Value(s)
8th Feb 202111:56 amRNSNet Asset Value(s)
5th Feb 20219:35 amRNSNet Asset Value(s)
4th Feb 202110:43 amRNSNet Asset Value(s)
3rd Feb 20219:44 amRNSNet Asset Value(s)
2nd Feb 20219:45 amRNSNet Asset Value(s)
1st Feb 202110:39 amRNSNet Asset Value(s)
29th Jan 20216:05 pmRNSTotal Voting Rights
29th Jan 202110:33 amRNSNet Asset Value(s)
28th Jan 202111:04 amRNSNet Asset Value(s)
27th Jan 202110:23 amRNSNet Asset Value(s)
26th Jan 202110:23 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.